From 2017 to 2019 we have been the agency in charge of communications to traumatologists, rheumatologists and physiotherapists for the new product Meritene Mobilis.
Below we describe the actions of all the communications that were made to these groups.
MAILING
With a selection of private practices in traumatology and rheumatology, three X-rays were sent to attract the attention of the traumatologist and motivate him/her to visit the product website. Creativity was provided by the Global Health Care agency.
The return on mailing was 4.4%.
TELEMARKETING
As a follow up to the mailing we called all the queries and the answers we received were as follows:
- They knew the MERITENE brand in general
- I really liked the creativity because it was funny
- The X-rays attracted a lot of attention
By telephone, we presented the novelty MOBILIS, explaining its Triple Action:
- ARTICULAR FLEXIBILITY (Hyaluronic Acid, Collagen and Vitamin C)
- MUSCLE STRENGTH (High quality proteins, Iron and Magnesium)
- BONE PROTECTION (Calcium and Vitamin D)
We request the email to send communications with permission with call recording and reading of data protection legend for compliance with the LOPD.
50% of the queries provided a contact email address.
and in 35% of the cases it was that of the physician.
EMALING
We send new product information through the following e-mail account
nestle@fdm.digital
in which we informed about the triple action of MERITENE MOBILIS.
We explained to the specialist that it is indicated for healthy adults who feel joint and/or muscle discomfort, stiffness, joint pain, mild inflammation or active people who practice sports and want to maintain their mobility and take care of themselves to feel good.
We inform the physician of the recommended dosage, as well as the best way of intake. We exposed its nutritional compatibility by not including lactose, gluten and added sugars in its composition.
The opening of shipments ranged from 19% to 24%.
SAMPLE SHIPMENT
All the above actions led to the sending of product samples, which ended the communication campaign for the new product.
